ID27078A - A NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- [2- (PIPERIDIN-1-IL) ETHOCYSI] PHENOCHYES -2- (4-METHODIC-PHENYL) BENZO [b] HYDROXORIDA TIOFEN - Google Patents

A NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- [2- (PIPERIDIN-1-IL) ETHOCYSI] PHENOCHYES -2- (4-METHODIC-PHENYL) BENZO [b] HYDROXORIDA TIOFEN

Info

Publication number: ID27078A
Authority: ID; Indonesia
Prior art keywords: phenochyes; hydroxorida; ethocysi; tiofen; methodic
Prior art date: 1999-07-29

Application number

IDP20000629D

Other languages

Indonesian (id)

Inventor

Julie Kay Bush

Preston Charles Conrad

Merlyn Gerard Flom

Wayne Douglas Luke

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-29

Filing date

2000-07-24

Publication date

2001-02-22

2000-07-24 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2001-02-22 Publication of ID27078A publication Critical patent/ID27078A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDP20000629D 1999-07-29 2000-07-24 A NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- [2- (PIPERIDIN-1-IL) ETHOCYSI] PHENOCHYES -2- (4-METHODIC-PHENYL) BENZO [b] HYDROXORIDA TIOFEN ID27078A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US14628699P	1999-07-29	1999-07-29
US14757099P	1999-08-06	1999-08-06
US14977399P	1999-08-19	1999-08-19

Publications (1)

Publication Number	Publication Date
ID27078A true ID27078A (en)	2001-02-22

Family

ID=27386379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP20000629D ID27078A (en)	1999-07-29	2000-07-24	A NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- [2- (PIPERIDIN-1-IL) ETHOCYSI] PHENOCHYES -2- (4-METHODIC-PHENYL) BENZO [b] HYDROXORIDA TIOFEN

Country Status (44)

Country	Link
EP (1)	EP1204656A2 (en)
JP (1)	JP2001064277A (en)
KR (1)	KR100697177B1 (en)
CN (1)	CN1138770C (en)
AR (1)	AR031073A1 (en)
AT (1)	AT502318A1 (en)
AU (1)	AU6335600A (en)
BE (1)	BE1013411A3 (en)
BR (1)	BR0003209A (en)
CA (1)	CA2314682A1 (en)
CO (1)	CO5180570A1 (en)
CZ (1)	CZ299311B6 (en)
DE (1)	DE10036854A1 (en)
DK (1)	DK200001151A (en)
DZ (1)	DZ3060A1 (en)
FI (1)	FI20001722L (en)
FR (1)	FR2796944B1 (en)
GB (1)	GB2352717A (en)
GR (1)	GR1004084B (en)
HR (1)	HRP20000503B1 (en)
HU (1)	HUP0003001A2 (en)
ID (1)	ID27078A (en)
IL (1)	IL137553A (en)
IT (1)	IT1318660B1 (en)
LT (1)	LT4790B (en)
LU (1)	LU90617B1 (en)
LV (1)	LV12623B (en)
MD (1)	MD2336G2 (en)
MX (1)	MXPA00007461A (en)
MY (1)	MY128764A (en)
NL (1)	NL1015821C2 (en)
NO (1)	NO20003879L (en)
PE (1)	PE20010385A1 (en)
PL (1)	PL341749A1 (en)
PT (1)	PT102502A (en)
RO (1)	RO121851B1 (en)
SE (1)	SE0002792L (en)
SG (1)	SG91296A1 (en)
SI (1)	SI20426A (en)
SV (1)	SV2002000132A (en)
TR (1)	TR200002206A2 (en)
TW (1)	TWI276437B (en)
UA (1)	UA72885C2 (en)
WO (1)	WO2001009116A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6335500A (en) *	1999-07-29	2001-02-19	Eli Lilly And Company	A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-metho yphenyl)benzo[b]thiophene hydrochloride
PL365472A1 (en) *	2000-05-08	2005-01-10	Eli Lilly And Company	Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
US7122203B2 (en)	2000-05-08	2006-10-17	Eli Lilly And Company	Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
EP1757291A3 (en) *	2000-05-08	2009-07-15	Eli Lilly & Company	Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-YL)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
EP1157996A1 (en) *	2000-05-23	2001-11-28	JENAPHARM GmbH	New solid forms of mesoprogestin 11beta-(4E-(hydroxyiminomethyl)-phenyl)-17alpha-methoxymethyl-17beta-methoxy-estra-4,9-dien-3-on
JP2004512333A (en) *	2000-10-20	2004-04-22	イーライ・リリー・アンド・カンパニー	Novel crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride
AU2002230409A1 (en)	2000-11-27	2002-06-03	Eli Lilly And Company	Process for preparing 3-aryl-benzo(b)thiophenes
CA2393720C (en) *	2002-07-12	2010-09-14	Eli Lilly And Company	Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP2233482A1 (en) *	2004-07-22	2010-09-29	Eli Lilly And Company	A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarboxamide hemisuccinate salt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5510357A (en) *	1995-02-28	1996-04-23	Eli Lilly And Company	Benzothiophene compounds as anti-estrogenic agents
SG64896A1 (en) *	1995-02-28	1999-05-25	Lilly Co Eli	Benzothiophene compounds intermediates compositions and methods
ZA9710262B (en) *	1996-11-19	1999-05-13	Lilly Co Eli	Process for the synthesis of benzothiophenes
ZA982877B (en) *	1997-04-09	1999-10-04	Lilly Co Eli	Treatment of central nervous system disorders with selective estrogen receptor modulators.

2000
- 2000-07-17 AU AU63356/00A patent/AU6335600A/en not_active Abandoned
- 2000-07-17 EP EP00950223A patent/EP1204656A2/en not_active Ceased
- 2000-07-17 WO PCT/US2000/016333 patent/WO2001009116A2/en not_active Ceased
- 2000-07-18 LV LVP-00-94A patent/LV12623B/en unknown
- 2000-07-21 RO ROA200000736A patent/RO121851B1/en unknown
- 2000-07-24 ID IDP20000629D patent/ID27078A/en unknown
- 2000-07-24 CZ CZ20002716A patent/CZ299311B6/en not_active IP Right Cessation
- 2000-07-25 HR HR20000503A patent/HRP20000503B1/en not_active IP Right Cessation
- 2000-07-27 TR TR2000/02206A patent/TR200002206A2/en unknown
- 2000-07-27 IL IL13755300A patent/IL137553A/en not_active IP Right Cessation
- 2000-07-27 NL NL1015821A patent/NL1015821C2/en not_active IP Right Cessation
- 2000-07-27 CO CO00056521A patent/CO5180570A1/en active IP Right Grant
- 2000-07-28 HU HU0003001A patent/HUP0003001A2/en unknown
- 2000-07-28 FI FI20001722A patent/FI20001722L/en unknown
- 2000-07-28 KR KR1020000043651A patent/KR100697177B1/en not_active Expired - Fee Related
- 2000-07-28 LU LU90617A patent/LU90617B1/en active
- 2000-07-28 MY MYPI20003453A patent/MY128764A/en unknown
- 2000-07-28 UA UA2000074563A patent/UA72885C2/en unknown
- 2000-07-28 IT IT2000MI001759A patent/IT1318660B1/en active
- 2000-07-28 PL PL00341749A patent/PL341749A1/en not_active Application Discontinuation
- 2000-07-28 NO NO20003879A patent/NO20003879L/en not_active Application Discontinuation
- 2000-07-28 CN CNB001222376A patent/CN1138770C/en not_active Expired - Fee Related
- 2000-07-28 PT PT102502A patent/PT102502A/en not_active IP Right Cessation
- 2000-07-28 DE DE10036854A patent/DE10036854A1/en not_active Withdrawn
- 2000-07-28 SI SI200000172A patent/SI20426A/en not_active IP Right Cessation
- 2000-07-28 JP JP2000228939A patent/JP2001064277A/en active Pending
- 2000-07-28 LT LT2000076A patent/LT4790B/en not_active IP Right Cessation
- 2000-07-28 SE SE0002792A patent/SE0002792L/en unknown
- 2000-07-28 BE BE2000/0478A patent/BE1013411A3/en not_active IP Right Cessation
- 2000-07-28 DK DK200001151A patent/DK200001151A/en not_active Application Discontinuation
- 2000-07-28 SG SG200004288A patent/SG91296A1/en unknown
- 2000-07-28 FR FR0009969A patent/FR2796944B1/en not_active Expired - Fee Related
- 2000-07-28 BR BR0003209-3A patent/BR0003209A/en not_active Application Discontinuation
- 2000-07-28 MD MDA20000162A patent/MD2336G2/en not_active IP Right Cessation
- 2000-07-28 AT AT0132400A patent/AT502318A1/en not_active Application Discontinuation
- 2000-07-28 AR ARP000103928A patent/AR031073A1/en unknown
- 2000-07-28 GB GB0018641A patent/GB2352717A/en not_active Withdrawn
- 2000-07-28 GR GR20000100265A patent/GR1004084B/en unknown
- 2000-07-28 SV SV2000000132A patent/SV2002000132A/en unknown
- 2000-07-28 CA CA002314682A patent/CA2314682A1/en not_active Abandoned
- 2000-07-28 TW TW089115154A patent/TWI276437B/en not_active IP Right Cessation
- 2000-07-28 MX MXPA00007461A patent/MXPA00007461A/en active IP Right Grant
- 2000-07-29 DZ DZ000126A patent/DZ3060A1/en active
- 2000-07-31 PE PE2000000757A patent/PE20010385A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
PT102502A (en)	2001-01-31
BE1013411A3 (en)	2001-12-04
WO2001009116A2 (en)	2001-02-08
IL137553A (en)	2005-09-25
AU6335600A (en)	2001-02-19
HRP20000503A2 (en)	2001-06-30
ITMI20001759A1 (en)	2002-01-28
MD2336F2 (en)	2003-12-31
MY128764A (en)	2007-02-28
NO20003879D0 (en)	2000-07-28
IE20000605A1 (en)	2001-04-04
NL1015821A1 (en)	2001-01-30
NL1015821C2 (en)	2002-01-03
SV2002000132A (en)	2002-06-07
DK200001151A (en)	2001-01-30
LT2000076A (en)	2001-02-26
DE10036854A1 (en)	2001-03-01
CZ299311B6 (en)	2008-06-18
AR031073A1 (en)	2003-09-10
WO2001009116A3 (en)	2001-05-17
RO121851B1 (en)	2008-06-30
CZ20002716A3 (en)	2001-05-16
JP2001064277A (en)	2001-03-13
HUP0003001A2 (en)	2002-04-29
CN1288007A (en)	2001-03-21
SG91296A1 (en)	2002-09-17
CO5180570A1 (en)	2002-07-30
EP1204656A2 (en)	2002-05-15
CN1138770C (en)	2004-02-18
DZ3060A1 (en)	2004-05-22
IT1318660B1 (en)	2003-08-27
GB2352717A (en)	2001-02-07
SE0002792L (en)	2001-01-30
NO20003879L (en)	2001-01-30
GR20000100265A (en)	2001-03-30
FI20001722A0 (en)	2000-07-28
FR2796944B1 (en)	2003-01-31
MD2336G2 (en)	2004-06-30
SE0002792D0 (en)	2000-07-28
IL137553A0 (en)	2001-07-24
HRP20000503B1 (en)	2008-04-30
MXPA00007461A (en)	2004-07-16
LV12623A (en)	2001-03-20
ITMI20001759A0 (en)	2000-07-28
TR200002206A2 (en)	2001-03-21
FR2796944A1 (en)	2001-02-02
GR1004084B (en)	2002-12-11
HU0003001D0 (en)	2000-10-28
PE20010385A1 (en)	2001-04-06
PL341749A1 (en)	2001-02-12
FI20001722A7 (en)	2001-01-30
MD20000162A (en)	2001-04-30
KR20010049916A (en)	2001-06-15
SI20426A (en)	2001-06-30
KR100697177B1 (en)	2007-03-21
TWI276437B (en)	2007-03-21
LT4790B (en)	2001-05-25
FI20001722L (en)	2001-01-30
LU90617B1 (en)	2001-06-15
BR0003209A (en)	2001-03-20
AT502318A1 (en)	2007-02-15
UA72885C2 (en)	2005-05-16
LV12623B (en)	2001-07-20
GB0018641D0 (en)	2000-09-13
CA2314682A1 (en)	2001-01-29
HK1035370A1 (en)	2001-11-23

Publication	Publication Date	Title
DK1341779T3 (en)	2006-10-30	Heterocyclic sulfonamide inhibitors of beta-amyloid production
ATE309998T1 (en)	2005-12-15	PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES
ID27078A (en)	2001-02-22	A NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- [2- (PIPERIDIN-1-IL) ETHOCYSI] PHENOCHYES -2- (4-METHODIC-PHENYL) BENZO [b] HYDROXORIDA TIOFEN
ATE253561T1 (en)	2003-11-15	2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-METHYL-N-( - MORPHOLINE-4-YL-4-O-TOLYL-PYRIDINE-3-YL)- ISOBUTYRAMIDE
ID26679A (en)	2001-02-01	NEW CRYSTAL FORM OF 6-HYDROXY-3- (4- (2- (PIPERIDIN-1-IL) ETHOCYSI) PHENOXICES -2 (4-METHODYPHENYL) BENSO (b) HYDROXLORIDA TIOFEN
NO983667L (en)	1998-12-17	Crystal modification of a pharmaceutical surfactant
ATE525362T1 (en)	2011-10-15	2-(3-(4-(2-T-BUTYL-6-TRIFLUORMETHYLPYRIMIDINE-4-
PL360946A1 (en)	2004-09-20	A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
IT1316627B1 (en)	2003-04-24	PROCEDURE FOR THE MANAGEMENT OF A MACHINE TOOL
NO20015095D0 (en)	2001-10-19	Process for the preparation of 2- (N-phenylamino) benzoic acids
ATE348605T1 (en)	2007-01-15	STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- (2-(PIPERIDIN-1-YL)ETHOXY)PHENOXY)-2-(4-METHOXYPHENYL)BENZO(B)THIOPHENE AND SALTS THEREOF
FI20001427A0 (en)	2000-06-15	Procedure for controlling movements of a crane
ATE414059T1 (en)	2008-11-15	CRYSTALLINE FORM OF THE SODIUM SALT OF 5-CHLORINE-2-METHOXY-N-(2-(4-METHOXY-3-METHYLAMINOTHIOCARBONYLAMINOSULFONYLPHENYL)ETHY )BNZAMIDE
HK1059258A (en)	2004-06-25	A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
TJ399B (en)	2004-12-29	A novel crystalline form of 6-hydroxy -3-(4-Ä2-(piperidin-1-yl) ethoxyÜ- phenoxy) -2-(4-methoxyphenyl) benzo ÄBÜ thiophene hydrochloride.
TJ398B (en)	2004-12-29	A novel crystalline form of 6-hydroxy -3-(4-Ä2-(piperidin-1-yl) ethoxyÜ-phenoxy) -2-(4-methoxyphenyl) benzo ÄbÜ thiophene hydrochloride.
ECSP003592A (en)	2001-02-21	A NEW CRYSTALINE SHAPE OF 6- HYDROXY- 3- (4- [2- (PIPERIDIN-1-IL) ETOXI] PHENOXI) -2- (4-METOXYPHENYL) BENZO [b] THIOPHEN
ITFI990074A0 (en)	1999-04-02	EQUIPMENT FOR THE REMOVAL OF A TEMPORARY PROSTHESIS CAPSULE